Purnanand Sarma
Direttore/Membro del Consiglio presso Ohm Oncology, Inc.
Patrimonio netto: 6 M $ in data 30/04/2024
Posizioni attive di Purnanand Sarma
Società | Posizione | Inizio | Fine |
---|---|---|---|
Ohm Oncology, Inc.
Ohm Oncology, Inc. Pharmaceuticals: MajorHealth Technology Ohm Oncology, Inc. is a drug development company. It treats drug resistant neoplasms and cancers with novel multi-mechanism compounds. The company was founded by Vamsi Maddipatla and Ram S. Upadhayaya and is headquartered in Austin, TX. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Purnanand Sarma
Precedenti posizioni note di Purnanand Sarma
Società | Posizione | Inizio | Fine |
---|---|---|---|
IMMUNOME, INC. | Direttore/Membro del Consiglio | 24/06/2019 | 02/10/2023 |
Amministratore Delegato | 24/06/2019 | 02/10/2023 | |
Presidente | 24/06/2019 | 02/10/2023 | |
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Direttore/Membro del Consiglio | 19/07/2010 | 03/01/2019 |
Amministratore Delegato | 20/07/2010 | 03/01/2019 | |
Presidente | 20/07/2010 | 03/01/2019 | |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | - | - |
Vaxess Technologies, Inc.
Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - | - |
Smithkline Beecham Pharmaceuticals (India) Ltd. | Corporate Officer/Principal | - | - |
NEKTAR THERAPEUTICS | Corporate Officer/Principal | - | - |
CIMA Labs, Inc.
CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | Corporate Officer/Principal | - | - |
Formazione di Purnanand Sarma
University of Minnesota | Doctorate Degree |
Andhra University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
India | 3 |
Posizioni
Director/Board Member | 4 |
Corporate Officer/Principal | 4 |
Chief Executive Officer | 2 |
Settori
Health Technology | 8 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
NEKTAR THERAPEUTICS | Health Technology |
IMMUNOME, INC. | Health Technology |
Aziende private | 6 |
---|---|
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Health Technology |
CIMA Labs, Inc.
CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | Health Technology |
Smithkline Beecham Pharmaceuticals (India) Ltd. | Health Technology |
Ohm Oncology, Inc.
Ohm Oncology, Inc. Pharmaceuticals: MajorHealth Technology Ohm Oncology, Inc. is a drug development company. It treats drug resistant neoplasms and cancers with novel multi-mechanism compounds. The company was founded by Vamsi Maddipatla and Ram S. Upadhayaya and is headquartered in Austin, TX. | Health Technology |
Vaxess Technologies, Inc.
Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA. | Commercial Services |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
- Borsa valori
- Insiders
- Purnanand Sarma
- Esperienza